Highlights

[PHARMA] YoY Annualized Quarter Result on 2011-12-31 [#4]

Stock [PHARMA]: PHARMANIAGA BHD
Announcement Date 22-Feb-2012
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2011
Quarter 31-Dec-2011  [#4]
Profit Trend QoQ -     -2.73%    YoY -     71.66%
Quarter Report


View:


Show?  YoY % Horiz. %

Annualized Quarter Result
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
Revenue 2,122,933 1,946,639 1,812,346 1,520,981 1,378,348 1,300,796 1,305,646 8.43%
  YoY % 9.06% 7.41% 19.16% 10.35% 5.96% -0.37% -
  Horiz. % 162.60% 149.09% 138.81% 116.49% 105.57% 99.63% 100.00%
PBT 125,580 92,997 103,313 73,186 45,462 81,436 90,599 5.59%
  YoY % 35.04% -9.99% 41.16% 60.98% -44.17% -10.11% -
  Horiz. % 138.61% 102.65% 114.03% 80.78% 50.18% 89.89% 100.00%
Tax -31,355 -36,236 -40,108 -20,401 -15,152 -19,709 -29,190 1.20%
  YoY % 13.47% 9.65% -96.60% -34.64% 23.12% 32.48% -
  Horiz. % 107.42% 124.14% 137.40% 69.89% 51.91% 67.52% 100.00%
NP 94,225 56,761 63,205 52,785 30,310 61,727 61,409 7.39%
  YoY % 66.00% -10.20% 19.74% 74.15% -50.90% 0.52% -
  Horiz. % 153.44% 92.43% 102.92% 85.96% 49.36% 100.52% 100.00%
NP to SH 93,844 55,200 61,710 52,157 30,384 60,191 60,031 7.73%
  YoY % 70.01% -10.55% 18.32% 71.66% -49.52% 0.27% -
  Horiz. % 156.33% 91.95% 102.80% 86.88% 50.61% 100.27% 100.00%
Tax Rate 24.97 % 38.96 % 38.82 % 27.88 % 33.33 % 24.20 % 32.22 % -4.16%
  YoY % -35.91% 0.36% 39.24% -16.35% 37.73% -24.89% -
  Horiz. % 77.50% 120.92% 120.48% 86.53% 103.45% 75.11% 100.00%
Total Cost 2,028,708 1,889,878 1,749,141 1,468,196 1,348,038 1,239,069 1,244,237 8.49%
  YoY % 7.35% 8.05% 19.14% 8.91% 8.79% -0.42% -
  Horiz. % 163.05% 151.89% 140.58% 118.00% 108.34% 99.58% 100.00%
Net Worth 525,526 486,754 471,886 514,273 421,524 431,158 388,297 5.17%
  YoY % 7.97% 3.15% -8.24% 22.00% -2.23% 11.04% -
  Horiz. % 135.34% 125.36% 121.53% 132.44% 108.56% 111.04% 100.00%
Dividend
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
Div 72,486 41,477 41,187 35,304 10,698 39,585 28,881 16.57%
  YoY % 74.76% 0.71% 16.66% 230.00% -72.97% 37.06% -
  Horiz. % 250.98% 143.61% 142.61% 122.24% 37.04% 137.06% 100.00%
Div Payout % 77.24 % 75.14 % 66.74 % 67.69 % 35.21 % 65.77 % 48.11 % 8.21%
  YoY % 2.79% 12.59% -1.40% 92.25% -46.46% 36.71% -
  Horiz. % 160.55% 156.18% 138.72% 140.70% 73.19% 136.71% 100.00%
Equity
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
Net Worth 525,526 486,754 471,886 514,273 421,524 431,158 388,297 5.17%
  YoY % 7.97% 3.15% -8.24% 22.00% -2.23% 11.04% -
  Horiz. % 135.34% 125.36% 121.53% 132.44% 108.56% 111.04% 100.00%
NOSH 258,880 258,911 117,677 117,682 106,985 106,987 106,968 15.86%
  YoY % -0.01% 120.02% -0.00% 10.00% -0.00% 0.02% -
  Horiz. % 242.01% 242.04% 110.01% 110.02% 100.02% 100.02% 100.00%
Ratio Analysis
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
NP Margin 4.44 % 2.92 % 3.49 % 3.47 % 2.20 % 4.75 % 4.70 % -0.94%
  YoY % 52.05% -16.33% 0.58% 57.73% -53.68% 1.06% -
  Horiz. % 94.47% 62.13% 74.26% 73.83% 46.81% 101.06% 100.00%
ROE 17.86 % 11.34 % 13.08 % 10.14 % 7.21 % 13.96 % 15.46 % 2.43%
  YoY % 57.50% -13.30% 28.99% 40.64% -48.35% -9.70% -
  Horiz. % 115.52% 73.35% 84.61% 65.59% 46.64% 90.30% 100.00%
Per Share
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
RPS 820.05 751.85 1,540.10 1,292.44 1,288.35 1,215.84 1,220.58 -6.41%
  YoY % 9.07% -51.18% 19.16% 0.32% 5.96% -0.39% -
  Horiz. % 67.19% 61.60% 126.18% 105.89% 105.55% 99.61% 100.00%
EPS 36.25 21.32 52.44 44.32 28.40 56.26 56.12 -7.02%
  YoY % 70.03% -59.34% 18.32% 56.06% -49.52% 0.25% -
  Horiz. % 64.59% 37.99% 93.44% 78.97% 50.61% 100.25% 100.00%
DPS 28.00 16.02 35.00 30.00 10.00 37.00 27.00 0.61%
  YoY % 74.78% -54.23% 16.67% 200.00% -72.97% 37.04% -
  Horiz. % 103.70% 59.33% 129.63% 111.11% 37.04% 137.04% 100.00%
NAPS 2.0300 1.8800 4.0100 4.3700 3.9400 4.0300 3.6300 -9.23%
  YoY % 7.98% -53.12% -8.24% 10.91% -2.23% 11.02% -
  Horiz. % 55.92% 51.79% 110.47% 120.39% 108.54% 111.02% 100.00%
Adjusted Per Share Value based on latest NOSH - 261,705
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
RPS 811.19 743.83 692.51 581.18 526.68 497.05 498.90 8.43%
  YoY % 9.06% 7.41% 19.16% 10.35% 5.96% -0.37% -
  Horiz. % 162.60% 149.09% 138.81% 116.49% 105.57% 99.63% 100.00%
EPS 35.86 21.09 23.58 19.93 11.61 23.00 22.94 7.73%
  YoY % 70.03% -10.56% 18.31% 71.66% -49.52% 0.26% -
  Horiz. % 156.32% 91.94% 102.79% 86.88% 50.61% 100.26% 100.00%
DPS 27.70 15.85 15.74 13.49 4.09 15.13 11.04 16.56%
  YoY % 74.76% 0.70% 16.68% 229.83% -72.97% 37.05% -
  Horiz. % 250.91% 143.57% 142.57% 122.19% 37.05% 137.05% 100.00%
NAPS 2.0081 1.8599 1.8031 1.9651 1.6107 1.6475 1.4837 5.17%
  YoY % 7.97% 3.15% -8.24% 22.00% -2.23% 11.04% -
  Horiz. % 135.34% 125.36% 121.53% 132.45% 108.56% 111.04% 100.00%
Price Multiplier on Financial Quarter End Date
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
Date 31/12/14 31/12/13 31/12/12 30/12/11 30/12/10 31/12/09 31/12/08 -
Price 4.5800 4.4500 8.1000 5.3600 5.3100 4.0000 3.3600 -
P/RPS 0.56 0.59 0.53 0.41 0.41 0.33 0.28 12.24%
  YoY % -5.08% 11.32% 29.27% 0.00% 24.24% 17.86% -
  Horiz. % 200.00% 210.71% 189.29% 146.43% 146.43% 117.86% 100.00%
P/EPS 12.63 20.87 15.45 12.09 18.70 7.11 5.99 13.23%
  YoY % -39.48% 35.08% 27.79% -35.35% 163.01% 18.70% -
  Horiz. % 210.85% 348.41% 257.93% 201.84% 312.19% 118.70% 100.00%
EY 7.91 4.79 6.47 8.27 5.35 14.07 16.70 -11.71%
  YoY % 65.14% -25.97% -21.77% 54.58% -61.98% -15.75% -
  Horiz. % 47.37% 28.68% 38.74% 49.52% 32.04% 84.25% 100.00%
DY 6.11 3.60 4.32 5.60 1.88 9.25 8.04 -4.47%
  YoY % 69.72% -16.67% -22.86% 197.87% -79.68% 15.05% -
  Horiz. % 76.00% 44.78% 53.73% 69.65% 23.38% 115.05% 100.00%
P/NAPS 2.26 2.37 2.02 1.23 1.35 0.99 0.93 15.94%
  YoY % -4.64% 17.33% 64.23% -8.89% 36.36% 6.45% -
  Horiz. % 243.01% 254.84% 217.20% 132.26% 145.16% 106.45% 100.00%
Price Multiplier on Announcement Date
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
Date 23/02/15 24/02/14 18/02/13 22/02/12 25/02/11 19/02/10 27/02/09 -
Price 5.2800 4.2900 7.8000 5.9000 5.3500 4.0500 2.7300 -
P/RPS 0.64 0.57 0.51 0.46 0.42 0.33 0.22 19.47%
  YoY % 12.28% 11.76% 10.87% 9.52% 27.27% 50.00% -
  Horiz. % 290.91% 259.09% 231.82% 209.09% 190.91% 150.00% 100.00%
P/EPS 14.57 20.12 14.87 13.31 18.84 7.20 4.86 20.07%
  YoY % -27.58% 35.31% 11.72% -29.35% 161.67% 48.15% -
  Horiz. % 299.79% 413.99% 305.97% 273.87% 387.65% 148.15% 100.00%
EY 6.87 4.97 6.72 7.51 5.31 13.89 20.56 -16.69%
  YoY % 38.23% -26.04% -10.52% 41.43% -61.77% -32.44% -
  Horiz. % 33.41% 24.17% 32.68% 36.53% 25.83% 67.56% 100.00%
DY 5.30 3.73 4.49 5.08 1.87 9.14 9.89 -9.87%
  YoY % 42.09% -16.93% -11.61% 171.66% -79.54% -7.58% -
  Horiz. % 53.59% 37.71% 45.40% 51.37% 18.91% 92.42% 100.00%
P/NAPS 2.60 2.28 1.95 1.35 1.36 1.00 0.75 23.01%
  YoY % 14.04% 16.92% 44.44% -0.74% 36.00% 33.33% -
  Horiz. % 346.67% 304.00% 260.00% 180.00% 181.33% 133.33% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View candlestick stock charts with Technical indicators
MQ Affiliate
Be rewarded by being an MQ Affiliate
 
 

782  345  529  807 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AT 0.20+0.03 
 VIVOCOM 0.805-0.05 
 IRIS 0.355+0.055 
 KANGER 0.180.00 
 EAH 0.035+0.005 
 XDL 0.070.00 
 ASIABIO-OR 0.01-0.025 
 KNM 0.205-0.005 
 KSTAR 0.305-0.03 
 AT-WC 0.20+0.045 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Jaks Resources - Jaks Hai Duong Power Plant Achieved Commercial Operation Date (COD) !!! DK
2. Should we buy Top Glove since it has been plunging due its 28 factories shut down? Koon Yew Yin Koon Yew Yin's Blog
3. Kelington Group Berhad ("KGB") - Above Expectations (TP: RM2.30; +35% upside) by Kenanga Research Investment Ideas - Value and Growth
4. TOP GLOVE LOCKDOWN AND SUPERMAX SHARE PRICE The way I see it
5. 【Growth成长股】AWC Berhad (7579) – Benefit from Strong Order Book Amounted Close to RM1Bil Sanitize and Disinfection Healthcare Stocks
6. Top Glove’s 28 factories shut down should benefit other glove makers - Koon Yew Yin Koon Yew Yin's Blog
7. VIVOCOM: End of Day Report (26 Nov 2020) See Jovin
8. O&G sector making a comeback: SERBA DINAMIK BERHAD the Winner! (TP: RM2.70 by KENANGA) KV Blog
PARTNERS & BROKERS